Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems Articles uri icon

publication date

  • January 2015

start page

  • 385

end page

  • 414

volume

  • 17

international standard serial number (ISSN)

  • 1523-9829

abstract

  • Positron emission tomography (PET) imaging is based on detecting two time-coincident high-energy photons from the emission of a positronemitting radioisotope. The physics of the emission, and the detection of the coincident photons, give PET imaging unique capabilities for both very high sensitivity and accurate estimation of the in vivo concentration of the radiotracer. PET imaging has been widely adopted as an important clinical modality for oncological, cardiovascular, and neurological applications. PET imaging has also become an important tool in preclinical studies, particularly for investigating murine models of disease and other small-animal models. However, there are several challenges to using PET imaging systems. These include the fundamental trade-offs between resolution and noise, the quantitative accuracy of the measurements, and integration with X-ray computed tomography and magnetic resonance imaging. In this article, we review how researchers and industry are addressing these challenges.

keywords

  • pet/ct; pet/mri; silicon photomultipliers; system model; tomographic image reconstruction; multimodality kinetic modeling; of flight pet; small animal pet; standardized uptake values; whole body pet; attenuation correction; scatter correction; quantitative assessment; performance evaluation; computed tomography; respiratory motion